Louis Joseph Nisbet

Amura Holdings Ltd. was engaged in drug discovery for diseases, such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria. The firm developed a technology platform that provided turnkey solutions for the discovery of small-molecule inhibitors against cysteine peptidases. The company was founded by Daniel James William Roach on June 6, 20005 and was headquartered in Cambridge, the United Kingdom.

Amura Ltd. manufactured, fabricated and processed drugs in pharmaceutical preparations. It offered drugs for human or veterinary use. The company was founded in 1996 and was headquartered in Cambridge, the United Kingdom.

Intouch with Health Ltd. delivers IT-based patient flow management solutions to help hospitals and private healthcare providers. Its solutions include calling, wait time manager, hospital wayfinding, flow manager, patient activity manager, and performance manager. The company was founded by Rohit Sethi and Paul Blackburn in 1999 and is headquartered in Cirencester, the United Kingdom.

Laboratoire Glaxosmithkline SAS manufactures pharmaceutical products. The company was founded in 2001 and is headquartered in Rueil-Malmaison, France.

Indigix Ltd. develops a novel platform technology that engineers synthetic molecules to modify immunological responses for diseases. Its applications include, treatment of diarrhoeal diseases, inflammatory bowel disease, and wound healing. The firm also provides pre-clinical testing services. The company was founded on June 11, 2010 and is headquartered in Solihull, the United Kingdom.

Amati Global Investors Ltd. (Venture Capital) is a Venture Capital firm, a subsidiary of Amati Global Investors Ltd. founded in 1999. The firm is headquartered in Edinburgh.

Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom.

BliNK Therapeutics Ltd. is a holding company which produces monoclonal antibodies using a novel platform. The platform technology provides a new way of activating the immune system’s B cells to produce antibodies in response to a specific antigen. The company was founded in 2011 and is headquartered in Marlow, the United Kingdom.

Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.

BioAscent Discovery Ltd. provides integrated drug discovery services. The firm offers compound management and compound reformatting services. Its products include readymade screening libraries, custom screening libraries and follow-up samples. The company was founded by Sylviane Boucharens in 2013 and is headquartered in Motherwell, the United Kingdom.

Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom.